Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(3R)-N-[(2S)-1-hydroxy-6-[(3R)-3-isocyanobutanamido]hexan-2-yl]-3-isocyanobutanamide biosynthesis
-
-
PWY-8320
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase)
-
-
PWY-7726
(5Z)-dodecenoate biosynthesis II
-
-
PWY-7858
(5Z)-icosenoate biosynthesis
-
-
PWY-5361
(8E,10E)-dodeca-8,10-dienol biosynthesis
-
-
PWY-7654
(9Z)-tricosene biosynthesis
-
-
PWY-7035
(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7216
(R)-cysteate degradation
-
-
PWY-6642
(S)-lactate fermentation to propanoate, acetate and hydrogen
-
-
PWY-8086
(S)-propane-1,2-diol degradation
-
-
PWY-7013
(S)-reticuline biosynthesis
-
-
(S)-reticuline biosynthesis I
-
-
PWY-3581
(S)-reticuline biosynthesis II
-
-
PWY-6133
1,3-propanediol biosynthesis (engineered)
-
-
PWY-7385
1,5-anhydrofructose degradation
-
-
PWY-6992
1-butanol autotrophic biosynthesis (engineered)
-
-
PWY-6886
1-methylpyrrolinium biosynthesis
-
-
PWY-5315
10-cis-heptadecenoyl-CoA degradation (yeast)
-
-
PWY-7337
10-trans-heptadecenoyl-CoA degradation (MFE-dependent, yeast)
-
-
PWY-7339
10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast)
-
-
PWY-7338
11-oxyandrogens biosynthesis
-
-
PWY-8202
15-epi-lipoxin biosynthesis
-
-
PWY66-393
2'-deoxymugineic acid phytosiderophore biosynthesis
-
-
PWY-5912
2-amino-3-hydroxycyclopent-2-enone biosynthesis
-
-
PWY-7536
2-arachidonoylglycerol biosynthesis
-
-
PWY-8052
2-deoxy-D-ribose degradation II
-
-
PWY-8058
2-methyl-branched fatty acid beta-oxidation
-
-
PWY-8181
2-methylpropene degradation
-
-
PWY-7778
2-nitrobenzoate degradation I
-
-
PWY-5647
2-nitrotoluene degradation
-
-
PWY-5641
2-oxoglutarate decarboxylation to succinyl-CoA
-
-
PWY-5084
2-oxoisovalerate decarboxylation to isobutanoyl-CoA
-
-
PWY-5046
24-epi-campesterol, fucosterol, and clionasterol biosynthesis (diatoms)
-
-
PWY-8238
3,5-dimethoxytoluene biosynthesis
-
-
PWY-7076
3-(4-hydroxyphenyl)pyruvate biosynthesis
-
-
PWY-5886
3-hydroxy-4-methyl-anthranilate biosynthesis I
-
-
PWY-7717
3-hydroxy-4-methyl-anthranilate biosynthesis II
-
-
PWY-7765
3-hydroxypropanoate cycle
-
-
PWY-5743
3-hydroxypropanoate/4-hydroxybutanate cycle
-
-
PWY-5789
3-hydroxyquinaldate biosynthesis
-
-
PWY-7733
3-methyl-branched fatty acid alpha-oxidation
-
-
PWY66-387
3-methylbutanol biosynthesis (engineered)
-
-
PWY-6871
3-phenylpropanoate degradation
-
-
P281-PWY
3-phosphoinositide biosynthesis
-
-
PWY-6352
3-phosphoinositide degradation
-
-
PWY-6368
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis II
-
-
PWY-7282
4-aminobutanoate degradation V
-
-
PWY-5022
4-ethylphenol degradation (anaerobic)
-
-
PWY-6080
4-hydroxy-2(1H)-quinolone biosynthesis
-
-
PWY-6661
4-hydroxy-2-nonenal detoxification
-
-
PWY-7112
4-hydroxybenzoate biosynthesis I (eukaryotes)
-
-
PWY-5754
4-hydroxybenzoate biosynthesis III (plants)
-
-
PWY-6435
4-nitrophenol degradation I
-
-
PWY-5487
4-nitrophenol degradation II
-
-
PWY-5488
4-oxopentanoate degradation
-
-
PWY-7948
6-gingerol analog biosynthesis (engineered)
-
-
PWY-6920
6-hydroxymethyl-dihydropterin diphosphate biosynthesis
-
-
6-hydroxymethyl-dihydropterin diphosphate biosynthesis I
-
-
PWY-6147
6-hydroxymethyl-dihydropterin diphosphate biosynthesis IV (Plasmodium)
-
-
PWY-7852
8-amino-7-oxononanoate biosynthesis I
-
-
PWY-6519
9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast)
-
-
PWY-7340
acetaldehyde biosynthesis I
-
-
PWY-6333
acetoacetate degradation (to acetyl CoA)
-
-
ACETOACETATE-DEG-PWY
acetone degradation I (to methylglyoxal)
-
-
PWY-5451
acetone degradation III (to propane-1,2-diol)
-
-
PWY-7466
acetyl CoA biosynthesis
-
-
acetyl-CoA biosynthesis from citrate
-
-
PWY-5172
acetyl-CoA fermentation to butanoate
-
-
PWY-5676
acetylene degradation (anaerobic)
-
-
P161-PWY
acridone alkaloid biosynthesis
-
-
PWY-5958
acrylate degradation I
-
-
PWY-6373
acrylonitrile degradation I
-
-
PWY-7308
adenine and adenosine salvage I
-
-
P121-PWY
adenine and adenosine salvage III
-
-
PWY-6609
adenine and adenosine salvage V
-
-
PWY-6611
adenine salvage
-
-
PWY-6610
adenosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7227
adenosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7220
adenosine nucleotides degradation I
-
-
PWY-6596
adenosine nucleotides degradation II
-
-
SALVADEHYPOX-PWY
adenosine ribonucleotides de novo biosynthesis
-
-
PWY-7219
adipate biosynthesis
-
-
PWY-8347
aerobic respiration I (cytochrome c)
-
-
PWY-3781
aerobic respiration II (cytochrome c) (yeast)
-
-
PWY-7279
aerobic respiration III (alternative oxidase pathway)
-
-
PWY-4302
aerobic toluene degradation
-
-
Aflatoxin biosynthesis
-
-
Alanine, aspartate and glutamate metabolism
-
-
alkane biosynthesis II
-
-
PWY-7033
alkane oxidation
-
-
PWY-2724
allantoin degradation
-
-
alliin metabolism
-
-
PWY-5706
alpha-linolenate metabolites biosynthesis
-
-
PWY-8398
alpha-Linolenic acid metabolism
-
-
alpha-tomatine degradation
-
-
PWY18C3-5
Amaryllidacea alkaloids biosynthesis
-
-
PWY-7826
Amino sugar and nucleotide sugar metabolism
-
-
Aminoacyl-tRNA biosynthesis
-
-
Aminobenzoate degradation
-
-
aminopropanol phosphate biosynthesis II
-
-
PWY-7378
aminopropylcadaverine biosynthesis
-
-
PWY0-1303
ammonia assimilation cycle I
-
-
PWY-6963
ammonia assimilation cycle II
-
-
PWY-6964
ammonia assimilation cycle III
-
-
AMMASSIM-PWY
ammonia oxidation II (anaerobic)
-
-
P303-PWY
amygdalin and prunasin degradation
-
-
PWY-6011
anaerobic energy metabolism (invertebrates, cytosol)
-
-
PWY-7383
anaerobic energy metabolism (invertebrates, mitochondrial)
-
-
PWY-7384
anandamide biosynthesis I
-
-
PWY-8051
anandamide biosynthesis II
-
-
PWY-8053
anandamide degradation
-
-
PWY6666-1
anandamide lipoxygenation
-
-
PWY-8056
anapleurotic synthesis of oxalacetate
-
-
androgen and estrogen metabolism
-
-
androgen biosynthesis
-
-
PWY66-378
androstenedione degradation I (aerobic)
-
-
PWY-6944
androstenedione degradation II (anaerobic)
-
-
PWY-8152
apratoxin A biosynthesis
-
-
PWY-8361
arachidonate biosynthesis
-
-
arachidonate biosynthesis I (6-desaturase, lower eukaryotes)
-
-
PWY-5353
arachidonate biosynthesis IV (8-detaturase, lower eukaryotes)
-
-
PWY-7601
arachidonate biosynthesis V (8-detaturase, mammals)
-
-
PWY-7725
arachidonate metabolites biosynthesis
-
-
PWY-8397
Arachidonic acid metabolism
-
-
arachidonic acid metabolism
-
-
Arginine and proline metabolism
-
-
Arginine biosynthesis
-
-
aromatic biogenic amine degradation (bacteria)
-
-
PWY-7431
arsenate detoxification I
-
-
PWY-8264
arsenic detoxification (mammals)
-
-
PWY-4202
arsenic detoxification (plants)
-
-
PWY-8259
arsenic detoxification (yeast)
-
-
PWY-4621
arsenite to oxygen electron transfer
-
-
PWY-4521
arsenite to oxygen electron transfer (via azurin)
-
-
PWY-7429
Ascorbate and aldarate metabolism
-
-
ascorbate glutathione cycle
-
-
PWY-2261
ascorbate recycling (cytosolic)
-
-
PWY-6370
aspartate and asparagine metabolism
-
-
aspirin triggered resolvin D biosynthesis
-
-
PWY66-395
aspirin triggered resolvin E biosynthesis
-
-
PWY66-394
astaxanthin biosynthesis (bacteria, fungi, algae)
-
-
PWY-5288
ATP biosynthesis
-
-
PWY-7980
atromentin biosynthesis
-
-
PWY-7518
bacilysin biosynthesis
-
-
PWY-7626
backdoor pathway of androgen biosynthesis
-
-
PWY-8200
bacterial bioluminescence
-
-
PWY-7723
baicalein degradation (hydrogen peroxide detoxification)
-
-
PWY-7214
base-degraded thiamine salvage
-
-
PWY-6899
benzoate biosynthesis I (CoA-dependent, beta-oxidative)
-
-
PWY-6443
benzoate biosynthesis III (CoA-dependent, non-beta-oxidative)
-
-
PWY-6446
benzoyl-CoA biosynthesis
-
-
PWY-6458
benzoyl-CoA degradation I (aerobic)
-
-
PWY-1361
beta-alanine biosynthesis I
-
-
PWY-3981
beta-alanine degradation I
-
-
BETA-ALA-DEGRADATION-I-PWY
beta-alanine degradation II
-
-
PWY-1781
beta-Alanine metabolism
-
-
beta-carboline biosynthesis
-
-
PWY-5877
beta-D-glucuronide and D-glucuronate degradation
-
-
PWY-7247
Betalain biosynthesis
-
-
betalamic acid biosynthesis
-
-
PWY-5394
betanidin degradation
-
-
PWY-5461
betaxanthin biosynthesis
-
-
PWY-5426
betaxanthin biosynthesis (via dopamine)
-
-
PWY-5403
Bifidobacterium shunt
-
-
P124-PWY
bile acid biosynthesis, neutral pathway
Biosynthesis of ansamycins
-
-
Biosynthesis of secondary metabolites
-
-
Biosynthesis of unsaturated fatty acids
-
-
Bisphenol degradation
-
-
bisucaberin biosynthesis
-
-
PWY-6381
brassinolide biosynthesis I
-
-
PWY-699
brassinolide biosynthesis II
-
-
PWY-2582
Brassinosteroid biosynthesis
-
-
bryostatin biosynthesis
-
-
PWY-8047
bupropion degradation
-
-
PWY66-241
butanoate fermentation
-
-
butanol and isobutanol biosynthesis (engineered)
-
-
PWY-7396
C20 prostanoid biosynthesis
-
-
PWY66-374
C4 and CAM-carbon fixation
-
-
C4 photosynthetic carbon assimilation cycle, NAD-ME type
-
-
PWY-7115
C4 photosynthetic carbon assimilation cycle, NADP-ME type
-
-
PWY-241
C4 photosynthetic carbon assimilation cycle, PEPCK type
-
-
PWY-7117
C5-Branched dibasic acid metabolism
-
-
cadaverine biosynthesis
-
-
PWY0-1601
Calvin-Benson-Bassham cycle
-
-
CALVIN-PWY
camalexin biosynthesis
-
-
CAMALEXIN-SYN
canavanine biosynthesis
-
-
PWY-5
canavanine degradation
-
-
PWY-31
cannabinoid biosynthesis
-
-
PWY-5140
Caprolactam degradation
-
-
capsaicin biosynthesis
-
-
PWY-5710
Carbapenem biosynthesis
-
-
Carbon fixation in photosynthetic organisms
-
-
Carbon fixation pathways in prokaryotes
-
-
Carotenoid biosynthesis
-
-
carotenoid biosynthesis
-
-
catechol degradation to 2-hydroxypentadienoate I
-
-
P183-PWY
catechol degradation to 2-hydroxypentadienoate II
-
-
PWY-5419
catecholamine biosynthesis
CDP-6-deoxy-D-gulose biosynthesis
-
-
PWY-8139
cell-surface glycoconjugate-linked phosphocholine biosynthesis
-
-
PWY-7886
cellulose degradation
-
-
cellulose degradation II (fungi)
-
-
PWY-6788
ceramide and sphingolipid recycling and degradation (yeast)
-
-
PWY-7119
ceramide biosynthesis
-
-
ceramide de novo biosynthesis
-
-
PWY3DJ-12
ceramide degradation (generic)
-
-
PWY-6483
ceramide degradation by alpha-oxidation
-
-
PWY66-388
chitin biosynthesis
-
-
PWY-6981
chitin deacetylation
-
-
PWY-7118
chitin degradation I (archaea)
-
-
PWY-6855
chitin degradation II (Vibrio)
-
-
PWY-6902
chitin degradation III (Serratia)
-
-
PWY-7822
Chloroalkane and chloroalkene degradation
-
-
Chlorocyclohexane and chlorobenzene degradation
-
-
chlorogenic acid degradation
-
-
PWY-6781
cholesterol biosynthesis
-
-
cholesterol biosynthesis (algae, late side-chain reductase)
-
-
PWY-8191
cholesterol biosynthesis (diatoms)
-
-
PWY-8239
cholesterol biosynthesis (plants, early side-chain reductase)
-
-
PWY18C3-1
cholesterol biosynthesis I
-
-
PWY66-341
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
-
-
PWY66-3
cholesterol degradation to androstenedione I (cholesterol oxidase)
-
-
PWY-6945
cholesterol degradation to androstenedione II (cholesterol dehydrogenase)
-
-
PWY-6946
cholesterol degradation to androstenedione III (anaerobic)
-
-
PWY-8151
choline biosynthesis III
-
-
PWY-3561
chondroitin sulfate degradation I (bacterial)
-
-
PWY-6572
chorismate biosynthesis from 3-dehydroquinate
-
-
PWY-6163
chorismate metabolism
-
-
cis-zeatin biosynthesis
-
-
PWY-2781
Citrate cycle (TCA cycle)
-
-
CMP phosphorylation
-
-
PWY-7205
CMP-2-keto-3-deoxy-D-glycero-D-galacto-nononate biosynthesis
-
-
PWY-6140
CMP-N-acetylneuraminate biosynthesis I (eukaryotes)
-
-
PWY-6138
CMP-N-acetylneuraminate biosynthesis II (bacteria)
-
-
PWY-6139
CMP-N-glycoloylneuraminate biosynthesis
-
-
PWY-6144
CO2 fixation in Crenarchaeota
-
-
CO2 fixation into oxaloacetate (anaplerotic)
-
-
PWYQT-4429
coenzyme B biosynthesis
-
-
P241-PWY
coenzyme M biosynthesis
-
-
coenzyme M biosynthesis II
-
-
PWY-6643
complex N-linked glycan biosynthesis (plants)
-
-
PWY-7920
complex N-linked glycan biosynthesis (vertebrates)
-
-
PWY-7426
coumarin biosynthesis (via 2-coumarate)
-
-
PWY-5176
creatine biosynthesis
-
-
GLYCGREAT-PWY
creatine phosphate biosynthesis
-
-
PWY-6158
crotonate fermentation (to acetate and cyclohexane carboxylate)
-
-
PWY-7401
crotonyl-CoA/ethylmalonyl-CoA/hydroxybutyryl-CoA cycle (engineered)
-
-
PWY-7854
curacin A biosynthesis
-
-
PWY-8358
cutin biosynthesis
-
-
PWY-321
Cutin, suberine and wax biosynthesis
-
-
Cyanoamino acid metabolism
-
-
cylindrospermopsin biosynthesis
-
-
PWY-8045
Cysteine and methionine metabolism
-
-
cytosolic NADPH production (yeast)
-
-
PWY-7268
D-Amino acid metabolism
-
-
D-galactose degradation I (Leloir pathway)
-
-
PWY-6317
D-galactose degradation II
-
-
GALDEG-PWY
D-gluconate degradation
-
-
GLUCONSUPER-PWY
D-myo-inositol (1,4,5)-trisphosphate biosynthesis
-
-
PWY-6351
D-myo-inositol (1,4,5)-trisphosphate degradation
-
-
PWY-6363
D-myo-inositol-5-phosphate metabolism
-
-
PWY-6367
D-sorbitol biosynthesis I
-
-
PWY-5054
D-sorbitol degradation I
-
-
PWY-4101
D-xylose degradation to ethylene glycol (engineered)
-
-
PWY-7178
degradation of aromatic, nitrogen containing compounds
-
-
degradation of hexoses
-
-
degradation of sugar acids
-
-
degradation of sugar alcohols
-
-
desferrioxamine B biosynthesis
-
-
PWY-6376
desferrioxamine E biosynthesis
-
-
PWY-6375
detoxification of reactive carbonyls in chloroplasts
-
-
PWY-6786
di-homo-gamma-linolenate metabolites biosynthesis
-
-
PWY-8396
di-trans,poly-cis-undecaprenyl phosphate biosynthesis
-
-
PWY-5785
diacylglycerol biosynthesis (PUFA enrichment in oilseed)
-
-
PWY-6804
dicranin biosynthesis
-
-
PWY-6603
diethylphosphate degradation
-
-
PWY-5491
dimethyl sulfide biosynthesis from methionine
-
-
PWY-7793
dimorphecolate biosynthesis
-
-
PWY-5368
dissimilatory sulfate reduction I (to hydrogen sufide))
-
-
DISSULFRED-PWY
divinyl ether biosynthesis II
-
-
PWY-5409
docosahexaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-7053
docosahexaenoate biosynthesis III (6-desaturase, mammals)
-
-
PWY-7606
docosahexaenoate metabolites biosynthesis
-
-
PWY-8400
dolichol and dolichyl phosphate biosynthesis
dopamine degradation
-
-
PWY6666-2
drosopterin and aurodrosopterin biosynthesis
-
-
PWY-7442
Drug metabolism - cytochrome P450
-
-
Drug metabolism - other enzymes
-
-
dTDP-beta-L-rhamnose biosynthesis
-
-
DTDPRHAMSYN-PWY
dTMP de novo biosynthesis (mitochondrial)
-
-
PWY66-385
dZTP biosynthesis
-
-
PWY-8289
Entner Doudoroff pathway
-
-
Entner-Doudoroff pathway I
-
-
PWY-8004
Entner-Doudoroff pathway II (non-phosphorylative)
-
-
NPGLUCAT-PWY
Entner-Doudoroff pathway III (semi-phosphorylative)
-
-
PWY-2221
ergothioneine biosynthesis I (bacteria)
-
-
PWY-7255
erythritol biosynthesis I
-
-
PWY-8372
erythritol biosynthesis II
-
-
PWY-8373
erythro-tetrahydrobiopterin biosynthesis I
-
-
PWY-5663
ethanol degradation I
-
-
ETOH-ACETYLCOA-ANA-PWY
ethanol degradation II
-
-
PWY66-21
ethanol degradation III
-
-
PWY66-161
ethanol degradation IV
-
-
PWY66-162
ethanolamine utilization
-
-
PWY0-1477
ethene biosynthesis I (plants)
-
-
ETHYL-PWY
ethene biosynthesis II (microbes)
-
-
PWY-6853
ethene biosynthesis III (microbes)
-
-
PWY-6854
ethene biosynthesis IV (engineered)
-
-
PWY-7126
ethene biosynthesis V (engineered)
-
-
PWY-7124
Ether lipid metabolism
-
-
Ethylbenzene degradation
-
-
ethylbenzene degradation (anaerobic)
-
-
PWY-481
ethylmalonyl-CoA pathway
-
-
PWY-5741
farnesylcysteine salvage pathway
-
-
PWY-6577
fatty acid alpha-oxidation I (plants)
-
-
PWY-2501
fatty acid beta-oxidation I (generic)
-
-
FAO-PWY
fatty acid beta-oxidation II (plant peroxisome)
-
-
PWY-5136
fatty acid beta-oxidation IV (unsaturated, even number)
-
-
PWY-5138
fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)
-
-
PWY-6837
fatty acid beta-oxidation VI (mammalian peroxisome)
-
-
PWY66-391
fatty acid beta-oxidation VII (yeast peroxisome)
-
-
PWY-7288
Fatty acid biosynthesis
-
-
fatty acid biosynthesis initiation (mitochondria)
-
-
PWY66-429
fatty acid biosynthesis initiation (plant mitochondria)
-
-
PWY-6799
fatty acid biosynthesis initiation (type I)
-
-
PWY-5966-1
fatty acid biosynthesis initiation (type II)
-
-
PWY-4381
Fatty acid degradation
-
-
Fatty acid elongation
-
-
fatty acid salvage
-
-
PWY-7094
Fe(II) oxidation
-
-
PWY-6692
FeMo cofactor biosynthesis
-
-
PWY-7710
ferrichrome A biosynthesis
-
-
PWY-7571
firefly bioluminescence
-
-
PWY-7913
flavin biosynthesis I (bacteria and plants)
-
-
RIBOSYN2-PWY
flavin biosynthesis II (archaea)
-
-
PWY-6167
flavin biosynthesis III (fungi)
-
-
PWY-6168
flavin salvage
-
-
PWY66-366
Flavone and flavonol biosynthesis
-
-
flexixanthin biosynthesis
-
-
PWY-7947
fluoroacetate and fluorothreonine biosynthesis
-
-
PWY-6644
folate transformations I
-
-
PWY-2201
folate transformations II (plants)
-
-
PWY-3841
folate transformations III (E. coli)
-
-
1CMET2-PWY
formaldehyde assimilation I (serine pathway)
-
-
PWY-1622
formaldehyde assimilation II (assimilatory RuMP Cycle)
-
-
PWY-1861
formaldehyde assimilation III (dihydroxyacetone cycle)
-
-
P185-PWY
formaldehyde oxidation I
-
-
RUMP-PWY
formate to nitrite electron transfer
-
-
PWY0-1585
fructose 2,6-bisphosphate biosynthesis
-
-
PWY66-423
Fructose and mannose metabolism
-
-
GABA shunt I
-
-
GLUDEG-I-PWY
GABA shunt II
-
-
PWY-8346
gamma-glutamyl cycle
-
-
PWY-4041
gamma-linolenate biosynthesis II (animals)
-
-
PWY-6000
ganglio-series glycosphingolipids biosynthesis
-
-
PWY-7836
GDP-alpha-D-glucose biosynthesis
-
-
PWY-5661
GDP-mannose biosynthesis
-
-
PWY-5659
ginsenoside metabolism
-
-
gliotoxin biosynthesis
-
-
PWY-7533
glucocorticoid biosynthesis
-
-
PWY66-381
gluconeogenesis I
-
-
GLUCONEO-PWY
gluconeogenesis II (Methanobacterium thermoautotrophicum)
-
-
PWY-6142
gluconeogenesis III
-
-
PWY66-399
glucose and glucose-1-phosphate degradation
-
-
GLUCOSE1PMETAB-PWY
glucose degradation (oxidative)
-
-
DHGLUCONATE-PYR-CAT-PWY
glucosylglycerol biosynthesis
-
-
PWY-7902
glutamate and glutamine metabolism
-
-
glutamate removal from folates
-
-
PWY-2161B
glutaminyl-tRNAgln biosynthesis via transamidation
-
-
PWY-5921
glutaryl-CoA degradation
-
-
PWY-5177
glutathione biosynthesis
-
-
GLUTATHIONESYN-PWY
glutathione degradation (DUG pathway)
-
-
PWY-7559
Glutathione metabolism
-
-
glutathione metabolism
-
-
glutathione-mediated detoxification I
-
-
PWY-4061
glutathione-mediated detoxification II
-
-
PWY-6842
glutathione-peroxide redox reactions
-
-
PWY-4081
glycerol degradation I
-
-
PWY-4261
glycerol degradation to butanol
-
-
PWY-7003
glycerol-3-phosphate shuttle
-
-
PWY-6118
glycerol-3-phosphate to cytochrome bo oxidase electron transfer
-
-
PWY0-1561
glycerol-3-phosphate to fumarate electron transfer
-
-
PWY0-1582
glycerol-3-phosphate to hydrogen peroxide electron transport
-
-
PWY0-1591
Glycerolipid metabolism
-
-
glycerophosphodiester degradation
-
-
PWY-6952
Glycerophospholipid metabolism
-
-
glycine betaine biosynthesis
-
-
glycine betaine degradation I
-
-
PWY-3661
glycine betaine degradation II (mammalian)
-
-
PWY-3661-1
glycine biosynthesis II
-
-
GLYCINE-SYN2-PWY
glycine cleavage
-
-
GLYCLEAV-PWY
Glycine, serine and threonine metabolism
-
-
glycogen biosynthesis
-
-
glycogen biosynthesis I (from ADP-D-Glucose)
-
-
GLYCOGENSYNTH-PWY
glycogen biosynthesis II (from UDP-D-Glucose)
-
-
PWY-5067
glycogen biosynthesis III (from alpha-maltose 1-phosphate)
-
-
PWY-7900
glycogen degradation I
-
-
GLYCOCAT-PWY
glycogen degradation II
-
-
PWY-5941
Glycolysis / Gluconeogenesis
-
-
glycolysis I (from glucose 6-phosphate)
-
-
GLYCOLYSIS
glycolysis II (from fructose 6-phosphate)
-
-
PWY-5484
glycolysis III (from glucose)
-
-
ANAGLYCOLYSIS-PWY
glycolysis IV
-
-
PWY-1042
glycolysis V (Pyrococcus)
-
-
P341-PWY
Glycosaminoglycan biosynthesis - heparan sulfate / heparin
-
-
Glycosaminoglycan degradation
-
-
Glycosphingolipid biosynthesis - ganglio series
-
-
Glycosphingolipid biosynthesis - globo and isoglobo series
-
-
Glycosphingolipid biosynthesis - lacto and neolacto series
-
-
Glyoxylate and dicarboxylate metabolism
-
-
glyoxylate assimilation
-
-
PWY-5744
glyoxylate cycle
-
-
GLYOXYLATE-BYPASS
guadinomine B biosynthesis
-
-
PWY-7693
guaiacol biosynthesis
-
-
PWY18C3-23
guanine and guanosine salvage I
-
-
PWY-6620
guanine and guanosine salvage II
-
-
PWY-6599
guanosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7226
guanosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7222
guanosine nucleotides degradation I
-
-
PWY-6607
guanosine nucleotides degradation II
-
-
PWY-6606
guanosine nucleotides degradation III
-
-
PWY-6608
guanosine ribonucleotides de novo biosynthesis
-
-
PWY-7221
heme degradation I
-
-
PWY-5874
heparan sulfate biosynthesis
-
-
PWY-6558
heterolactic fermentation
-
-
P122-PWY
histamine degradation
-
-
PWY-6181
homocysteine and cysteine interconversion
-
-
PWY-801
homoglutathione biosynthesis
-
-
PWY-6840
homospermidine biosynthesis I
-
-
PWY-5907
homospermidine biosynthesis II
-
-
PWY-8149
hyaluronan degradation
-
-
PWY-7645
hydrogen sulfide biosynthesis II (mammalian)
-
-
PWY66-426
hydrogen to fumarate electron transfer
-
-
PWY0-1576
hydroxycinnamic acid serotonin amides biosynthesis
-
-
PWY-5473
hydroxycinnamic acid tyramine amides biosynthesis
-
-
PWY-5474
hydroxylated fatty acid biosynthesis (plants)
-
-
PWY-6433
hypoglycin biosynthesis
-
-
PWY-5826
hypotaurine degradation
-
-
PWY-7387
icosapentaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-6958
icosapentaenoate biosynthesis II (6-desaturase, mammals)
-
-
PWY-7049
icosapentaenoate biosynthesis III (8-desaturase, mammals)
-
-
PWY-7724
icosapentaenoate biosynthesis V (8-desaturase, lower eukaryotes)
-
-
PWY-7602
icosapentaenoate metabolites biosynthesis
-
-
PWY-8399
incomplete reductive TCA cycle
-
-
P42-PWY
indole glucosinolate activation (intact plant cell)
-
-
PWYQT-4477
indole-3-acetate biosynthesis II
-
-
PWY-581
indole-3-acetate biosynthesis III (bacteria)
-
-
PWY-3161
indole-3-acetate biosynthesis IV (bacteria)
-
-
PWY-5025
indole-3-acetate biosynthesis VI (bacteria)
-
-
TRPIAACAT-PWY
inosine 5'-phosphate degradation
-
-
PWY-5695
inosine-5'-phosphate biosynthesis I
-
-
PWY-6123
inosine-5'-phosphate biosynthesis II
-
-
PWY-6124
inosine-5'-phosphate biosynthesis III
-
-
PWY-7234
Inositol phosphate metabolism
-
-
Insect hormone biosynthesis
-
-
inulin degradation
-
-
PWY-8314
isoleucine metabolism
-
-
isoprene biosynthesis II (engineered)
-
-
PWY-7391
isoprenoid biosynthesis
-
-
isopropanol biosynthesis (engineered)
-
-
PWY-6876
Isoquinoline alkaloid biosynthesis
-
-
jadomycin biosynthesis
-
-
PWY-6679
jasmonic acid biosynthesis
-
-
PWY-735
juniperonate biosynthesis
-
-
PWY-7619
justicidin B biosynthesis
-
-
PWY-6824
ketogenesis
-
-
PWY66-367
ketogluconate metabolism
-
-
L-alanine biosynthesis II
-
-
ALANINE-SYN2-PWY
L-alanine degradation II (to D-lactate)
-
-
ALACAT2-PWY
L-alanine degradation III
-
-
ALANINE-DEG3-PWY
L-alanine degradation V (oxidative Stickland reaction)
-
-
PWY-8189
L-alanine degradation VI (reductive Stickland reaction)
-
-
PWY-8188
L-arginine biosynthesis I (via L-ornithine)
-
-
ARGSYN-PWY
L-arginine biosynthesis II (acetyl cycle)
-
-
ARGSYNBSUB-PWY
L-arginine biosynthesis III (via N-acetyl-L-citrulline)
-
-
PWY-5154
L-arginine biosynthesis IV (archaea)
-
-
PWY-7400
L-arginine degradation I (arginase pathway)
-
-
ARGASEDEG-PWY
L-arginine degradation V (arginine deiminase pathway)
-
-
ARGDEGRAD-PWY
L-arginine degradation VI (arginase 2 pathway)
-
-
ARG-PRO-PWY
L-arginine degradation VII (arginase 3 pathway)
-
-
ARG-GLU-PWY
L-arginine degradation X (arginine monooxygenase pathway)
-
-
ARGDEG-V-PWY
L-arginine degradation XIII (reductive Stickland reaction)
-
-
PWY-8187
L-arginine degradation XIV (oxidative Stickland reaction)
-
-
PWY-6344
L-ascorbate biosynthesis IV (animals, D-glucuronate pathway)
-
-
PWY3DJ-35471
L-ascorbate biosynthesis VI (plants, myo-inositol pathway)
-
-
PWY-8142
L-ascorbate biosynthesis VIII (engineered pathway)
-
-
PWY-7165
L-ascorbate degradation II (bacterial, aerobic)
-
-
PWY-6961
L-ascorbate degradation III
-
-
PWY-6960
L-asparagine biosynthesis III (tRNA-dependent)
-
-
PWY490-4
L-asparagine degradation III (mammalian)
-
-
ASPARAGINE-DEG1-PWY-1
L-aspartate biosynthesis
-
-
ASPARTATESYN-PWY
L-aspartate degradation I
-
-
ASPARTATE-DEG1-PWY
L-aspartate degradation II (aerobic)
-
-
PWY-8291
L-aspartate degradation III (anaerobic)
-
-
PWY-8294
L-carnitine degradation II
-
-
PWY-3641
L-citrulline biosynthesis
-
-
CITRULBIO-PWY
L-citrulline degradation
-
-
CITRULLINE-DEG-PWY
L-cysteine biosynthesis I
-
-
CYSTSYN-PWY
L-cysteine biosynthesis III (from L-homocysteine)
-
-
HOMOCYSDEGR-PWY
L-cysteine biosynthesis VI (reverse transsulfuration)
-
-
PWY-I9
L-cysteine degradation I
-
-
CYSTEINE-DEG-PWY
L-dopa and L-dopachrome biosynthesis
-
-
PWY-6481
L-dopa degradation I (mammalian)
-
-
PWY-6334
L-dopa degradation II (bacterial)
-
-
PWY-8110
L-glutamate biosynthesis I
-
-
GLUTSYN-PWY
L-glutamate degradation I
-
-
GLUTAMATE-DEG1-PWY
L-glutamate degradation II
-
-
GLUTDEG-PWY
L-glutamate degradation IX (via 4-aminobutanoate)
-
-
PWY0-1305
L-glutamate degradation V (via hydroxyglutarate)
-
-
P162-PWY
L-glutamate degradation VI (to pyruvate)
-
-
PWY-5087
L-glutamate degradation XI (reductive Stickland reaction)
-
-
PWY-8190
L-glutamine biosynthesis I
-
-
GLNSYN-PWY
L-glutamine degradation I
-
-
GLUTAMINDEG-PWY
L-histidine degradation I
-
-
HISDEG-PWY
L-histidine degradation II
-
-
PWY-5028
L-histidine degradation III
-
-
PWY-5030
L-histidine degradation V
-
-
PWY-5031
L-histidine degradation VI
-
-
HISHP-PWY
L-homoserine biosynthesis
-
-
HOMOSERSYN-PWY
L-idonate degradation
-
-
IDNCAT-PWY
L-isoleucine biosynthesis I (from threonine)
-
-
ILEUSYN-PWY
L-isoleucine biosynthesis II
-
-
PWY-5101
L-isoleucine biosynthesis III
-
-
PWY-5103
L-isoleucine biosynthesis IV
-
-
PWY-5104
L-isoleucine degradation I
-
-
ILEUDEG-PWY
L-isoleucine degradation II
-
-
PWY-5078
L-lactaldehyde degradation
-
-
L-leucine degradation III
-
-
PWY-5076
L-lysine biosynthesis IV
-
-
LYSINE-AMINOAD-PWY
L-lysine biosynthesis V
-
-
PWY-3081
L-lysine degradation I
-
-
PWY0-461
L-lysine degradation V
-
-
PWY-5283
L-lysine degradation X
-
-
PWY-6328
L-lysine degradation XI
-
-
LYSINE-DEG1-PWY
L-lysine fermentation to acetate and butanoate
-
-
P163-PWY
L-malate degradation II
-
-
PWY-7686
L-methionine biosynthesis I
-
-
HOMOSER-METSYN-PWY
L-methionine biosynthesis II
-
-
PWY-702
L-methionine biosynthesis III
-
-
HSERMETANA-PWY
L-methionine degradation I (to L-homocysteine)
-
-
METHIONINE-DEG1-PWY
L-methionine degradation III
-
-
PWY-5082
L-methionine salvage from L-homocysteine
-
-
ADENOSYLHOMOCYSCAT-PWY
L-Ndelta-acetylornithine biosynthesis
-
-
PWY-6922
L-nicotianamine biosynthesis
-
-
PWY-5957
L-ornithine biosynthesis II
-
-
ARGININE-SYN4-PWY
L-phenylalanine biosynthesis I
-
-
PHESYN
L-phenylalanine biosynthesis II
-
-
PWY-3462
L-phenylalanine degradation II (anaerobic)
-
-
ANAPHENOXI-PWY
L-phenylalanine degradation III
-
-
PWY-5079
L-phenylalanine degradation IV (mammalian, via side chain)
-
-
PWY-6318
L-phenylalanine degradation VI (reductive Stickland reaction)
-
-
PWY-8014
L-proline biosynthesis I (from L-glutamate)
-
-
PROSYN-PWY
L-proline degradation I
-
-
PROUT-PWY
L-serine biosynthesis II
-
-
PWY-8011
L-threonine degradation II
-
-
THREONINE-DEG2-PWY
L-threonine degradation III (to methylglyoxal)
-
-
THRDLCTCAT-PWY
L-tryptophan biosynthesis
-
-
TRPSYN-PWY
L-tryptophan degradation I (via anthranilate)
-
-
TRPCAT-PWY
L-tryptophan degradation IV (via indole-3-lactate)
-
-
TRPKYNCAT-PWY
L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5651
L-tryptophan degradation V (side chain pathway)
-
-
PWY-3162
L-tryptophan degradation VI (via tryptamine)
-
-
PWY-3181
L-tryptophan degradation VIII (to tryptophol)
-
-
PWY-5081
L-tryptophan degradation X (mammalian, via tryptamine)
-
-
PWY-6307
L-tryptophan degradation XI (mammalian, via kynurenine)
-
-
PWY-6309
L-tryptophan degradation XII (Geobacillus)
-
-
PWY-6505
L-tryptophan degradation XIII (reductive Stickland reaction)
-
-
PWY-8017
L-tyrosine biosynthesis I
-
-
TYRSYN
L-tyrosine biosynthesis II
-
-
PWY-3461
L-tyrosine biosynthesis III
-
-
PWY-6120
L-tyrosine degradation I
-
-
TYRFUMCAT-PWY
L-tyrosine degradation II
-
-
PWY-5151
L-tyrosine degradation III
-
-
PWY3O-4108
L-tyrosine degradation IV (to 4-methylphenol)
-
-
PWY-7514
L-tyrosine degradation V (reductive Stickland reaction)
-
-
PWY-8016
L-valine biosynthesis
-
-
VALSYN-PWY
L-valine degradation II
-
-
PWY-5057
lactose degradation III
-
-
BGALACT-PWY
lanosterol biosynthesis
-
-
PWY-6132
leukotriene biosynthesis
-
-
PWY66-375
Limonene and pinene degradation
-
-
limonene degradation IV (anaerobic)
-
-
PWY-8029
linamarin degradation
-
-
PWY-3121
linoleate biosynthesis I (plants)
-
-
PWY-5995
linoleate biosynthesis II (animals)
-
-
PWY-6001
linoleate metabolites biosynthesis
-
-
PWY-8395
Linoleic acid metabolism
-
-
linustatin bioactivation
-
-
PWY-7091
lipid A-core biosynthesis (E. coli K-12)
-
-
LIPA-CORESYN-PWY
lipid IVA biosynthesis (2,3-diamino-2,3-dideoxy-D-glucopyranose-containing)
-
-
PWY2B4Q-4
lipid IVA biosynthesis (E. coli)
-
-
NAGLIPASYN-PWY
lipid IVA biosynthesis (generic)
-
-
PWY-8283
lipid IVA biosynthesis (H. pylori)
-
-
PWYI-14
lipid IVA biosynthesis (P. gingivalis)
-
-
PWY-8245
lipid IVA biosynthesis (P. putida)
-
-
PWY-8073
lipid IVA biosynthesis (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY2G6Z-2
Lipopolysaccharide biosynthesis
-
-
lipoxin biosynthesis
-
-
PWY66-392
long chain fatty acid ester synthesis (engineered)
-
-
PWY-6873
long-chain fatty acid activation
-
-
PWY-5143
lotaustralin degradation
-
-
PWY-6002
lupanine biosynthesis
-
-
PWY-5468
luteolin triglucuronide degradation
-
-
PWY-7445
malate/L-aspartate shuttle pathway
-
-
MALATE-ASPARTATE-SHUTTLE-PWY
manganese oxidation I
-
-
PWY-6591
maresin biosynthesis
-
-
PWY-8356
matairesinol biosynthesis
-
-
PWY-5466
melatonin degradation I
-
-
PWY-6398
melatonin degradation II
-
-
PWY-6399
metabolism of amino sugars and derivatives
-
-
metabolism of disaccharids
-
-
Metabolism of xenobiotics by cytochrome P450
-
-
Methanobacterium thermoautotrophicum biosynthetic metabolism
-
-
PWY-6146
methanofuran biosynthesis
-
-
PWY-5254
methanol oxidation to formaldehyde IV
-
-
PWY-5506
methiin metabolism
-
-
PWY-7614
methionine metabolism
-
-
methyl indole-3-acetate interconversion
-
-
PWY-6303
methyl ketone biosynthesis (engineered)
-
-
PWY-7007
methyl tert-butyl ether degradation
-
-
PWY-7779
methylerythritol phosphate pathway I
-
-
NONMEVIPP-PWY
methylerythritol phosphate pathway II
-
-
PWY-7560
methylglyoxal degradation
-
-
methylglyoxal degradation I
-
-
PWY-5386
methylglyoxal degradation VIII
-
-
PWY-5386-1
methylsalicylate degradation
-
-
PWY18C3-24
mevalonate metabolism
-
-
mevalonate pathway I (eukaryotes and bacteria)
-
-
PWY-922
mevalonate pathway II (haloarchaea)
-
-
PWY-6174
mevalonate pathway III (Thermoplasma)
-
-
PWY-7524
mevalonate pathway IV (archaea)
-
-
PWY-8125
Microbial metabolism in diverse environments
-
-
mineralocorticoid biosynthesis
-
-
PWY66-382
mitochondrial L-carnitine shuttle
-
-
PWY-6111
mitochondrial NADPH production (yeast)
-
-
PWY-7269
mixed acid fermentation
-
-
FERMENTATION-PWY
monoacylglycerol metabolism (yeast)
-
-
PWY-7420
mRNA capping I
-
-
PWY-7375
Mucin type O-glycan biosynthesis
-
-
mupirocin biosynthesis
-
-
PWY-8012
muropeptide degradation
-
-
PWY0-1546
mycobactin biosynthesis
-
-
PWY185E-1
mycothiol biosynthesis
-
-
PWY1G-0
myo-inositol biosynthesis
myo-inositol degradation I
-
-
P562-PWY
N-Glycan biosynthesis
-
-
NAD phosphorylation and dephosphorylation
-
-
NADPHOS-DEPHOS-PWY
NAD phosphorylation and transhydrogenation
-
-
NADPHOS-DEPHOS-PWY-1
NAD salvage (plants)
-
-
PWY-5381
NAD salvage pathway III (to nicotinamide riboside)
-
-
NAD-BIOSYNTHESIS-II
NAD salvage pathway V (PNC V cycle)
-
-
PWY3O-4107
NAD(P)/NADPH interconversion
-
-
PWY-5083
NADH to cytochrome bd oxidase electron transfer I
-
-
PWY0-1334
NADH to cytochrome bo oxidase electron transfer I
-
-
PWY0-1335
NADH to fumarate electron transfer
-
-
PWY0-1336
NADPH to cytochrome c oxidase via plastocyanin
-
-
PWY-8271
Naphthalene degradation
-
-
neolinustatin bioactivation
-
-
PWY-7092
Neomycin, kanamycin and gentamicin biosynthesis
-
-
Nicotinate and nicotinamide metabolism
-
-
nicotine degradation IV
-
-
PWY66-201
nicotine degradation V
-
-
PWY66-221
nitrate reduction I (denitrification)
-
-
DENITRIFICATION-PWY
nitrate reduction IX (dissimilatory)
-
-
PWY0-1581
nitrate reduction VII (denitrification)
-
-
PWY-6748
nitrate reduction X (dissimilatory, periplasmic)
-
-
PWY0-1584
nitric oxide biosynthesis II (mammals)
-
-
PWY-4983
nitrifier denitrification
-
-
PWY-7084
nitrite-dependent anaerobic methane oxidation
-
-
PWY-6523
nitrogen remobilization from senescing leaves
-
-
PWY-6549
Nitrotoluene degradation
-
-
nocardicin A biosynthesis
-
-
PWY-7797
noradrenaline and adrenaline degradation
-
-
PWY-6342
Novobiocin biosynthesis
-
-
nucleoside and nucleotide degradation (archaea)
-
-
PWY-5532
O-Antigen nucleotide sugar biosynthesis
-
-
o-diquinones biosynthesis
-
-
PWY-6752
octopamine biosynthesis
-
-
PWY-7297
oleandomycin activation/inactivation
-
-
PWY-6972
oleate beta-oxidation
-
-
PWY0-1337
oleate beta-oxidation (isomerase-dependent, yeast)
-
-
PWY-7291
oleate biosynthesis I (plants)
-
-
PWY-5147
oleate biosynthesis II (animals and fungi)
-
-
PWY-5996
One carbon pool by folate
-
-
ophthalmate biosynthesis
-
-
PWY-8043
Other glycan degradation
-
-
Other types of O-glycan biosynthesis
-
-
oxidative decarboxylation of pyruvate
-
-
Oxidative phosphorylation
-
-
oxidative phosphorylation
-
-
palmitate biosynthesis II (type II fatty acid synthase)
-
-
PWY-5971
palmitate biosynthesis III
-
-
PWY-8279
palmitoleate biosynthesis IV (fungi and animals)
-
-
PWY3O-1801
palmitoyl ethanolamide biosynthesis
-
-
PWY-8055
Pantothenate and CoA biosynthesis
-
-
pantothenate biosynthesis
-
-
partial TCA cycle (obligate autotrophs)
-
-
PWY-5913
pederin biosynthesis
-
-
PWY-8049
Penicillin and cephalosporin biosynthesis
-
-
pentachlorophenol degradation
-
-
PCPDEG-PWY
Pentose and glucuronate interconversions
-
-
Pentose phosphate pathway
-
-
pentose phosphate pathway
-
-
pentose phosphate pathway (non-oxidative branch) I
-
-
NONOXIPENT-PWY
pentose phosphate pathway (non-oxidative branch) II
-
-
PWY-8178
pentose phosphate pathway (oxidative branch) I
-
-
OXIDATIVEPENT-PWY
pentose phosphate pathway (partial)
-
-
P21-PWY
peptido-conjugates in tissue regeneration biosynthesis
-
-
PWY-8355
Peptidoglycan biosynthesis
-
-
peptidoglycan biosynthesis
-
-
peptidoglycan recycling I
-
-
PWY0-1261
peptidoglycan recycling II
-
-
PWY-7883
Phenazine biosynthesis
-
-
phenylacetate degradation (aerobic)
-
-
phenylacetate degradation I (aerobic)
-
-
PWY0-321
Phenylalanine metabolism
-
-
phenylalanine metabolism
-
-
Phenylalanine, tyrosine and tryptophan biosynthesis
-
-
phenylethanol biosynthesis
-
-
PWY-5751
phenylethylamine degradation I
-
-
2PHENDEG-PWY
Phenylpropanoid biosynthesis
-
-
pheomelanin biosynthesis
-
-
PWY-7917
phosphate acquisition
-
-
PWY-6348
phosphatidate biosynthesis (yeast)
-
-
PWY-7411
phosphatidate metabolism, as a signaling molecule
-
-
PWY-7039
phosphatidylcholine acyl editing
-
-
PWY-6803
phosphatidylcholine biosynthesis I
-
-
PWY3O-450
phosphatidylcholine biosynthesis II
-
-
PWY4FS-2
phosphatidylcholine biosynthesis VII
-
-
PWY-7470
phosphatidylcholine resynthesis via glycerophosphocholine
-
-
PWY-7367
phosphatidylethanolamine biosynthesis II
-
-
PWY4FS-6
phosphatidylethanolamine bioynthesis
-
-
phospholipases
-
-
LIPASYN-PWY
phospholipid remodeling (phosphatidate, yeast)
-
-
PWY-7417
phospholipid remodeling (phosphatidylcholine, yeast)
-
-
PWY-7416
phospholipid remodeling (phosphatidylethanolamine, yeast)
-
-
PWY-7409
Phosphonate and phosphinate metabolism
-
-
phosphopantothenate biosynthesis I
-
-
PANTO-PWY
photosynthesis light reactions
-
-
PWY-101
photosynthetic 3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7218
phytate degradation I
-
-
PWY-4702
phytol degradation
-
-
PWY66-389
phytosterol biosynthesis (plants)
-
-
PWY-2541
plasmalogen biosynthesis I (aerobic)
-
-
PWY-7782
plasmalogen degradation
-
-
PWY-7783
plastoquinol-9 biosynthesis I
-
-
PWY-1581
platensimycin biosynthesis
-
-
PWY-8179
poly-hydroxy fatty acids biosynthesis
-
-
PWY-6710
polyhydroxybutanoate biosynthesis
-
-
PWY1-3
Porphyrin and chlorophyll metabolism
-
-
ppGpp metabolism
-
-
PPGPPMET-PWY
preQ0 biosynthesis
-
-
PWY-6703
Primary bile acid biosynthesis
-
-
procollagen hydroxylation and glycosylation
-
-
PWY-7894
progesterone biosynthesis
-
-
PWY-7299
propanethial S-oxide biosynthesis
-
-
PWY-5707
propanoate fermentation to 2-methylbutanoate
-
-
PWY-5109
Propanoate metabolism
-
-
propanoyl-CoA degradation II
-
-
PWY-7574
propionate fermentation
-
-
protectin biosynthesis
-
-
PWY-8357
protective electron sinks in the thylakoid membrane (PSII to PTOX)
-
-
PWY1YI0-7
protein citrullination
-
-
PWY-4921
protein N-glycosylation processing phase (endoplasmic reticulum, yeast)
-
-
PWY-7918
protein N-glycosylation processing phase (plants and animals)
-
-
PWY-7919
protein ubiquitination
-
-
PWY-7511
psilocybin biosynthesis
-
-
PWY-7936
purine deoxyribonucleosides degradation I
-
-
PWY-7179
purine deoxyribonucleosides degradation II
-
-
PWY-7179-1
purine deoxyribonucleosides salvage
-
-
PWY-7224
purine ribonucleosides degradation
-
-
PWY0-1296
putrescine biosynthesis III
-
-
PWY-46
putrescine degradation I
-
-
PUTDEG-PWY
putrescine degradation III
-
-
PWY-0
putrescine degradation IV
-
-
PWY-2
putrescine degradation V
-
-
PWY-3
pyridoxal 5'-phosphate salvage I
-
-
PLPSAL-PWY
pyridoxal 5'-phosphate salvage II (plants)
-
-
PWY-7204
pyrimidine deoxyribonucleosides salvage
-
-
PWY-7199
pyrimidine deoxyribonucleotide phosphorylation
-
-
PWY-7197
pyrimidine deoxyribonucleotides biosynthesis from CTP
-
-
PWY-7210
pyrimidine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7184
pyrimidine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7187
pyrimidine deoxyribonucleotides de novo biosynthesis III
-
-
PWY-6545
pyrimidine deoxyribonucleotides de novo biosynthesis IV
-
-
PWY-7198
pyrimidine deoxyribonucleotides dephosphorylation
-
-
PWY-7206
Pyrimidine metabolism
-
-
pyrimidine metabolism
-
-
pyruvate decarboxylation to acetyl CoA I
-
-
PYRUVDEHYD-PWY
pyruvate decarboxylation to acetyl CoA II
-
-
PWY-6970
pyruvate fermentation to (R)-acetoin I
-
-
PWY-5938
pyruvate fermentation to (R)-acetoin II
-
-
PWY-5939
pyruvate fermentation to (R)-lactate
-
-
PWY-8274
pyruvate fermentation to (S)-acetoin
-
-
PWY-6389
pyruvate fermentation to (S)-lactate
-
-
PWY-5481
pyruvate fermentation to acetone
-
-
PWY-6588
pyruvate fermentation to butanoate
-
-
CENTFERM-PWY
pyruvate fermentation to butanol I
-
-
PWY-6583
pyruvate fermentation to butanol II (engineered)
-
-
PWY-6883
pyruvate fermentation to ethanol I
-
-
PWY-5480
pyruvate fermentation to ethanol II
-
-
PWY-5486
pyruvate fermentation to ethanol III
-
-
PWY-6587
pyruvate fermentation to hexanol (engineered)
-
-
PWY-6863
pyruvate fermentation to isobutanol (engineered)
-
-
PWY-7111
pyruvate fermentation to propanoate I
-
-
P108-PWY
quinoxaline-2-carboxylate biosynthesis
-
-
PWY-7734
reactive oxygen species degradation
-
-
DETOX1-PWY-1
reductive TCA cycle I
-
-
P23-PWY
reductive TCA cycle II
-
-
PWY-5392
resolvin D biosynthesis
-
-
PWY66-397
retinol biosynthesis
-
-
PWY-6857
Riboflavin metabolism
-
-
ricinoleate biosynthesis
-
-
PWY-7618
rosmarinic acid biosynthesis I
-
-
PWY-5048
rosmarinic acid biosynthesis II
-
-
PWY-5049
Rubisco shunt
-
-
PWY-5723
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine biosynthesis
-
-
PWY-8301
S-adenosyl-L-methionine biosynthesis
-
-
SAM-PWY
S-adenosyl-L-methionine salvage I
-
-
PWY-6151
S-adenosyl-L-methionine salvage II
-
-
PWY-5041
S-methyl-L-methionine cycle
-
-
PWY-5441
salidroside biosynthesis
-
-
PWY-6802
salinosporamide A biosynthesis
-
-
PWY-6627
saponin biosynthesis II
-
-
PWY-5756
sciadonate biosynthesis
-
-
PWY-6598
secologanin and strictosidine biosynthesis
-
-
PWY-5290
sedoheptulose bisphosphate bypass
-
-
PWY0-1517
seleno-amino acid biosynthesis (plants)
-
-
PWY-6936
seleno-amino acid detoxification and volatilization I
-
-
PWY-6931
seleno-amino acid detoxification and volatilization III
-
-
PWY-6933
Selenocompound metabolism
-
-
serotonin and melatonin biosynthesis
-
-
PWY-6030
serotonin degradation
-
-
PWY-6313
sesamin biosynthesis
-
-
PWY-5469
Sesquiterpenoid and triterpenoid biosynthesis
-
-
sitosterol degradation to androstenedione
-
-
PWY-6948
sophorosyloxydocosanoate deacetylation
-
-
SOPHOROSYLOXYDOCOSANOATE-DEG-PWY
sorbitol biosynthesis II
-
-
PWY-5530
sorgoleone biosynthesis
-
-
PWY-5987
spermidine biosynthesis I
-
-
BSUBPOLYAMSYN-PWY
spermidine biosynthesis III
-
-
PWY-6834
spermine biosynthesis
-
-
ARGSPECAT-PWY
sphingolipid biosynthesis (mammals)
-
-
PWY-7277
sphingolipid biosynthesis (plants)
-
-
PWY-5129
Sphingolipid metabolism
-
-
sphingomyelin metabolism
-
-
PWY3DJ-11281
sphingosine and sphingosine-1-phosphate metabolism
-
-
PWY3DJ-11470
sphingosine metabolism
-
-
Spodoptera littoralis pheromone biosynthesis
-
-
PWY-7656
sporopollenin precursors biosynthesis
-
-
PWY-6733
Starch and sucrose metabolism
-
-
starch biosynthesis
-
-
PWY-622
starch degradation I
-
-
PWY-842
starch degradation III
-
-
PWY-6731
starch degradation V
-
-
PWY-6737
stearate biosynthesis I (animals)
-
-
PWY-5972
stearate biosynthesis II (bacteria and plants)
-
-
PWY-5989
stearate biosynthesis IV
-
-
PWY-8280
Steroid hormone biosynthesis
-
-
sterol biosynthesis (methylotrophs)
-
-
PWY-8026
sterol:steryl ester interconversion (yeast)
-
-
PWY-7424
streptomycin biosynthesis
-
-
PWY-5940
Streptomycin biosynthesis
-
-
suberin monomers biosynthesis
-
-
PWY-1121
succinate to chytochrome c oxidase via cytochrome c6
-
-
PWY1YI0-2
succinate to cytochrome bd oxidase electron transfer
-
-
PWY0-1353
succinate to cytochrome bo oxidase electron transfer
-
-
PWY0-1329
succinate to cytochrome c oxidase via plastocyanin
-
-
PWY1YI0-3
succinate to plastoquinol oxidase
-
-
PWY1YI0-8
sucrose biosynthesis I (from photosynthesis)
-
-
SUCSYN-PWY
sucrose biosynthesis II
-
-
PWY-7238
sucrose biosynthesis III
-
-
PWY-7347
sucrose degradation II (sucrose synthase)
-
-
PWY-3801
sucrose degradation III (sucrose invertase)
-
-
PWY-621
sucrose degradation IV (sucrose phosphorylase)
-
-
PWY-5384
sucrose degradation V (sucrose alpha-glucosidase)
-
-
PWY66-373
sulfated glycosaminoglycan metabolism
-
-
sulfide oxidation IV (mitochondria)
-
-
PWY-7927
sulfite oxidation II
-
-
PWY-5279
sulfite oxidation III
-
-
PWY-5278
sulfolactate degradation III
-
-
PWY-6638
sulfopterin metabolism
-
-
sulfur volatiles biosynthesis
-
-
PWY-6736
superoxide radicals degradation
-
-
DETOX1-PWY
superpathway of fatty acid biosynthesis initiation
-
-
FASYN-INITIAL-PWY
superpathway of fermentation (Chlamydomonas reinhardtii)
-
-
PWY4LZ-257
superpathway of glucose and xylose degradation
-
-
PWY-6901
superpathway of glycolysis and the Entner-Doudoroff pathway
-
-
GLYCOLYSIS-E-D
superpathway of glyoxylate cycle and fatty acid degradation
-
-
PWY-561
superpathway of methylsalicylate metabolism
-
-
PWY18C3-25
superpathway of ornithine degradation
-
-
ORNDEG-PWY
superpathway of photosynthetic hydrogen production
-
-
PWY-7731
superpathway of polyamine biosynthesis II
-
-
POLYAMINSYN3-PWY
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli)
-
-
PWY0-166
Taurine and hypotaurine metabolism
-
-
taurine biosynthesis I
-
-
PWY-5331
taurine biosynthesis II
-
-
PWY-7850
taurine biosynthesis III
-
-
PWY-8359
TCA cycle I (prokaryotic)
-
-
TCA
TCA cycle II (plants and fungi)
-
-
PWY-5690
TCA cycle III (animals)
-
-
PWY66-398
TCA cycle IV (2-oxoglutarate decarboxylase)
-
-
P105-PWY
TCA cycle V (2-oxoglutarate synthase)
-
-
PWY-6969
TCA cycle VI (Helicobacter)
-
-
REDCITCYC
TCA cycle VII (acetate-producers)
-
-
PWY-7254
TCA cycle VIII (Chlamydia)
-
-
TCA-1
teichuronic acid biosynthesis (B. subtilis 168)
-
-
PWY-7820
Terpenoid backbone biosynthesis
-
-
testosterone and androsterone degradation to androstendione (aerobic)
-
-
PWY-6943
tetrahydrofolate biosynthesis I
-
-
PWY-6614
tetrahydrofolate metabolism
-
-
tetrahydromonapterin biosynthesis
-
-
PWY0-1433
tetrapyrrole biosynthesis I (from glutamate)
-
-
PWY-5188
tetrapyrrole biosynthesis II (from glycine)
-
-
PWY-5189
thiamine diphosphate biosynthesis I (E. coli)
-
-
PWY-6894
thiamine diphosphate biosynthesis II (Bacillus)
-
-
PWY-6893
thiamine diphosphate biosynthesis III (Staphylococcus)
-
-
PWY-6907
thiamine diphosphate biosynthesis IV (eukaryotes)
-
-
PWY-6908
thiamine diphosphate salvage I
-
-
PWY-6896
thiamine diphosphate salvage II
-
-
PWY-6897
thiamine diphosphate salvage III
-
-
PWY-6898
thiamine diphosphate salvage IV (yeast)
-
-
PWY-7356
thioredoxin pathway
-
-
THIOREDOX-PWY
thiosulfate disproportionation IV (rhodanese)
-
-
PWY-5350
threo-tetrahydrobiopterin biosynthesis
-
-
PWY-6983
thymine degradation
-
-
PWY-6430
thyroid hormone biosynthesis
thyroid hormone metabolism I (via deiodination)
-
-
PWY-6260
thyroid hormone metabolism II (via conjugation and/or degradation)
-
-
PWY-6261
toluene degradation II (aerobic) (via 4-methylcatechol)
-
-
TOLUENE-DEG-3-OH-PWY
toluene degradation to 2-hydroxypentadienoate (via toluene-cis-diol)
-
-
TOLUENE-DEG-DIOL-PWY
toluene degradation to 2-hydroxypentadienoate I (via o-cresol)
-
-
TOLUENE-DEG-2-OH-PWY
traumatin and (Z)-3-hexen-1-yl acetate biosynthesis
-
-
PWY-5410
trehalose biosynthesis I
-
-
TRESYN-PWY
trehalose degradation I (low osmolarity)
-
-
TREDEGLOW-PWY
trehalose degradation II (cytosolic)
-
-
PWY0-1182
trehalose degradation IV
-
-
PWY-2722
trehalose degradation V
-
-
PWY-2723
triacylglycerol degradation
-
-
LIPAS-PWY
tRNA charging
-
-
TRNA-CHARGING-PWY
tRNA processing
-
-
PWY0-1479
Tropane, piperidine and pyridine alkaloid biosynthesis
-
-
Tryptophan metabolism
-
-
tryptophan metabolism
-
-
tunicamycin biosynthesis
-
-
PWY-7821
type IV lipoteichoic acid biosynthesis (S. pneumoniae)
-
-
PWY-7818
Ubiquinone and other terpenoid-quinone biosynthesis
-
-
UDP-alpha-D-glucose biosynthesis
-
-
PWY-7343
UDP-alpha-D-glucuronate biosynthesis (from UDP-glucose)
-
-
PWY-7346
UDP-N-acetyl-D-galactosamine biosynthesis II
-
-
PWY-5514
UDP-N-acetyl-D-galactosamine biosynthesis III
-
-
PWY-8013
UDP-N-acetyl-D-glucosamine biosynthesis I
-
-
UDPNAGSYN-PWY
UDP-N-acetyl-D-glucosamine biosynthesis II
-
-
UDPNACETYLGALSYN-PWY
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing)
-
-
PWY-6387
UDP-N-acetylmuramoyl-pentapeptide biosynthesis II (lysine-containing)
-
-
PWY-6386
UDP-N-acetylmuramoyl-pentapeptide biosynthesis III (meso-diaminopimelate containing)
-
-
PWY-7953
ultra-long-chain fatty acid biosynthesis
-
-
PWY-8041
UMP biosynthesis I
-
-
PWY-5686
UMP biosynthesis II
-
-
PWY-7790
UMP biosynthesis III
-
-
PWY-7791
uracil degradation I (reductive)
-
-
PWY-3982
urate conversion to allantoin I
-
-
PWY-5691
urate conversion to allantoin II
-
-
PWY-7394
urate conversion to allantoin III
-
-
PWY-7849
urea degradation II
-
-
PWY-5704
UTP and CTP de novo biosynthesis
-
-
PWY-7176
UTP and CTP dephosphorylation I
-
-
PWY-7185
Valine, leucine and isoleucine biosynthesis
-
-
Valine, leucine and isoleucine degradation
-
-
valproate beta-oxidation
-
-
PWY-8182
vancomycin resistance I
-
-
PWY-6454
vancomycin resistance II
-
-
PWY-6455
vanillin biosynthesis I
-
-
PWY-5665
Various types of N-glycan biosynthesis
-
-
very long chain fatty acid biosynthesis I
-
-
PWY-5080
very long chain fatty acid biosynthesis II
-
-
PWY-7036
vitamin B1 metabolism
-
-
Vitamin B6 metabolism
-
-
vitamin B6 metabolism
-
-
vitamin E biosynthesis (tocopherols)
-
-
PWY-1422
wax esters biosynthesis II
-
-
PWY-5885
xanthine and xanthosine salvage
-
-
SALVPURINE2-PWY
xanthommatin biosynthesis
-
-
PWY-8249
xyloglucan degradation II (exoglucanase)
-
-
PWY-6807
zymosterol biosynthesis
-
-
PWY-6074
adipate degradation
-
-
PWY-8354
bile acid biosynthesis, neutral pathway
-
-
PWY-6061
bile acid biosynthesis, neutral pathway
-
-
catecholamine biosynthesis
-
-
PWY66-301
catecholamine biosynthesis
-
-
cyanate degradation
-
-
CYANCAT-PWY
dolichol and dolichyl phosphate biosynthesis
-
-
PWY-6129
dolichol and dolichyl phosphate biosynthesis
-
-
methylaspartate cycle
-
-
PWY-6728
methylaspartate cycle
-
-
myo-inositol biosynthesis
-
-
PWY-2301
myo-inositol biosynthesis
-
-
octane oxidation
-
-
P221-PWY
thyroid hormone biosynthesis
-
-
PWY-6241
thyroid hormone biosynthesis
-
-
urea cycle
-
-
PWY-4984
vitamin K-epoxide cycle
-
-
PWY-7999
vitamin K-epoxide cycle
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
myofibril
brenda
-
high hexokinase activity
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
AANAT2 is expressed only in the muscular layer
brenda
-
brenda
-
no glucokinase transcript detected. Activity declines with both fasting and refeeding
brenda
-
-
brenda
AANAT2 is expressed only in the muscular layer
brenda
-
brenda
esophagus, stomach, pyloric ceca, foregut, midgut, hindgut. AANAT2 is expressed only in the muscular layer of all segments. No significant differences are obtained among the different segments evaluated
brenda
-
-
brenda
-
brenda
-
cardiac ventricular myofibrils
brenda
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
weak expression of subunit A, moderate expression of subunit B
brenda
-
brenda
-
-
brenda
-
during the larval developmental stage, male fish show higher expression levels of both subunits of gene than females
brenda
-
-
brenda
-
the highest expression of subunit A is observed in mature oocyte samples, while post ovulatory oocytes show the lowest copy numbers of the gene. Post-ovulatory oocyte shows the lowest expression level of subunit B
brenda
-
-
brenda
-
postheparin
brenda
-
-
brenda
-
brenda
-
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
-
activity in refed fish is higher than that of fed fish. Activity in refed fish is higher than that of fed fish
brenda
-
-
brenda
-
-
brenda
-
brenda
-
brenda
highest mRNA levels
brenda
-
increase in enzyme activity in presponse to feeding, during 4 h, then decrease to basal levels at 6 h. Fasting produces down-regulation of enzyme activity, concomitant with low levels of plasma insulin. Stimulation of enzyme activity by injection of insulin, especially stimulation of the proportion of enzyme in active conformation at the extracellular level
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
-
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
brenda
-
all regions of the brain except for the spinal cord and the optic nerve
brenda
-
cortex and anterior brain, striatum and middle brain, posterior brain
brenda
-
cortex and anterior brain, striatum and middle brain, posterior brain, low enzyme activity
brenda
-
glutamine synthetase activity is relatively low in all adult tissues examined, except brain
brenda
low level of mRNA expression
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
weak expression of subunit A, moderate expression of subunit B
brenda
-
-
brenda
primary hepatic amd gill epithelial cells
brenda
-
-
brenda
-
low enzyme activity
brenda
-
unfertilized
brenda
-
unfertilized mature eggs
brenda
-
-
brenda
-
hatchling
brenda
-
transcript levels steadily increased from day 28 post-fertilization to hatch
brenda
-
brenda
high activity
brenda
induction of anemia causes 30-60fold increase in anaemic animals
brenda
-
nucleated
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
209691, 210452, 639242, 665012, 665836, 665857, 673823, 690376, 703292, 703402, 710781, 733937, 746201
brenda
-
enzyme is stimulated in presence of 3 mg and 5 mg of Cd on the first day of experiment in gill, liver and kidney tissues. The stimulation effect of the 5 mg/l dose of Cd on G6PD and 6PGD enzyme activities is significantly diminished after seven days. The G6PD enzyme activity levels are stimulated by approximately 60% in gills
brenda
-
high enzyme activity
brenda
-
high expression of subunit A, moderate expression of subunit B
brenda
intermediate activity
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
brenda
low activity
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
weak expression of subunit A, weak expression of subunit B
brenda
-
brenda
AANAT2 is expressed only in the muscular layer
brenda
-
-
brenda
-
expression is altered by feeding conditions, especially in liver and hypothalamus where food deprivation decreases and refeeding increases expression. Activity in refed fish is higher than that of fed fish
brenda
-
brenda
-
crude intestine extract, mid-gut, 10-12 h after feeding
brenda
high level of mRNA expression
brenda
-
significant pretranslational up-regulation of acox1 expression in the anterior intestine after feeding
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
34293, 171041, 391710, 488759, 640657, 651409, 656415, 665836, 673823, 683526, 690377, 703292, 710781, 722081, 733937, 746201
brenda
-
activity significantly decreases with fasting
brenda
-
enzyme activity of G6PD enzyme is significantly stimulated after three days in liver and kidney tissues at a dose of 1 mg/l Cdand is stimulated on the first day of experiment in gill, liver and kidney tissues at doses of 3 and 5 mg/l Cd. The stimulation effect of the 5 mg/l dose of Cd on G6PD and 6PGD enzyme activities is significantly diminished after seven days. The G6PDenzyme activity levels are stimulated by approximately 67% in kidney
brenda
-
head kidney, weak expression of subunit A, high expression of subunit B
brenda
-
high enzyme activity
brenda
-
Leydig cells and inter-renal cells of head kidney
brenda
low activity
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney. Arginase 1a is often higher than arginase 1b, with highest expression seen in the posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
trunk
brenda
-
trunk kidney, moderate expression of subunit A, highest expression of subunit B
brenda
A0A060X964, A0SZ82, B6ETP4, I3PU26, Q8QHL7, Q90WG6, Q98T97, Q9PT36, Q9PT39, Q9W6Y2, V9ITC5
-
34293, 80856, 80975, 134923, 209242, 209243, 285444, 285614, 389981, 391710, 393342, 395388, 395389, 396609, 438217, 439369, 486613, 486816, 487118, 488436, 637910, 639100, 640137, 640674, 644848, 645268, 645280, 651409, 654322, 659842, 665015, 673374, 673823, 683526, 685368, 686233, 686368, 690376, 690377, 701088, 702944, 703290, 703292, 703294, 703402, 703782, 704831, 704902, 710781, 722081, 723747, 725617, 746201, 764194
brenda
-
activity significantly decreases with fasting. Activity in refed fish is higher than that of fed fish
brenda
-
enzyme activity of G6PD enzyme is significantly stimulated after three days in liver and kidney tissues at a dose of 1 mg/l Cd and is stimulated on the first day of experiment in gill, liver and kidney tissues at doses of 3 and 5 mg/l Cd. The stimulation effect of the 5 mg/l dose of Cd on G6PD and 6PGD enzyme activities is significantly diminished after seven days. The G6PDenzyme activity levels are stimulated by approximately 68% in liver
brenda
-
high expression of subunit A, weak expression of subunit B
brenda
high level of mRNA expression
brenda
highest enzyme level
brenda
-
specific activity is 33fold lower than in testis
brenda
-
the four genes coding for glutamine synthetase (Onmy-GS01, Onmy-GS02, Onmy-GS03 and Onmy-GS04) are expressed during early development, but only Onmy-GS01 and GS02 are expressed at appreciable levels in adult liver
brenda
-
thyronine 5'-deiodinase type I
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
-
brenda
-
activity significantly decreases with fasting. Activity in refed fish is higher than that of fed fish
brenda
-
-
brenda
AANAT2 is expressed only in the muscular layer
brenda
-
brenda
low activity
brenda
-
red muscle
brenda
-
red or white muscle, no stimulation of enzyme activity after injection of insulin
brenda
-
red, white and heart muscle
brenda
-
skeletal muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
weak expression of subunit A, weak expression of subunit B
brenda
-
-
brenda
-
ovarian
brenda
-
brenda
-
at late vitellogenesis stage, moderate expression of subunit A, highest expression of subunit B
brenda
-
at the late vitellogenesis stage, high expression of subunit A. Highest expression of subunit B is observed in ovary at late vitellogenesis stage
brenda
-
-
brenda
-
the enzyme catalyzes the first step in melatonin biosynthesis, melatonin biosynthesis follows a day and night rhythm, which is different in fasted, fed, and refed fish, overview
brenda
-
brenda
AANAT2 is expressed only in the muscular layer
brenda
-
brenda
-
hepatoma cell line
brenda
-
brenda
-
very low expression
brenda
-
white skeletal muscle
brenda
-
brenda
-
high expression of subunit A, moderate expression of subunit B
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
expression of CMP-KDN synthetase is temporally correlated with development and parallels the developmental expression of (KDN)GM3 in sperm
brenda
-
flagella isolated from
brenda
-
brenda
low activity
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
-
weak expression of subunit A, moderate expression of subunit B
brenda
-
brenda
AANAT2 is expressed only in the muscular layer
brenda
-
high expression of subunit A, highest expression of subunit B
brenda
-
brenda
-
at stage II, moderate expression of subunit A, weak expression of subunit B
brenda
-
non-flagellated germ cells and sperm cells
brenda
-
the highest expression of subunit B is observed in testis stage VIII, while the weakest signal of subunit B is at testis stage III. Testis stages IV-V show relatively high expression of subunit B, while a moderate expression is observed at testis stages I and II
brenda
-
-
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle
brenda
tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver
brenda
additional information
-
-
brenda
additional information
-
activities in intestine and erythrocytes are very low and probably not physiologically relevant. No activity in the heart
brenda
additional information
-
no enzymatic activity in any tissue other than liver and kidney
brenda
additional information
no expression detected in heart, kidney and spleen
brenda
additional information
-
no expression in white muscle
brenda
additional information
-
no signal: brain, pituitary, gill, heart, liver, pyloric caeca, intestine, ovary, muscle, skin, blood
brenda
additional information
-
tissue distribution
brenda
additional information
-
tissue distribution of enzyme activity, overview
brenda
additional information
-
tissue distribution of soluble and membrane enzyme activity, overview
brenda
additional information
tissue distribution pattern
brenda
additional information
unlike isoenzyme TCAb, isoenzyme TCAc lacks tissue specificity and may be expressed in the cytoplasm of all cells
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.